Company / Current Assets
NEUROONE MEDICAL TECHNOLOGIES Corp Current Assets History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$10.2M
FY2025
5-year range
$4.2M / $12.2M
FY2021-FY2025
Trend
+120.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets returned to growth in FY2025 after 2 years of decline, reaching $10M.
Based on SEC 10-K filings.
$10M in FY2025 with a 10-year CAGR of +136.9%.
Improved from $7M to $10M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -5.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- +136.9%
Key checks
Key Insights
- 3-year CAGR of -5.7%, indicating a declining trend.
- In FY2025, current assets increased 120.8% year-over-year.
- Peak current assets was recorded in FY2022.
- Lowest current assets in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.2M | +120.8% |
| FY2024 | $4.6M | -36.7% |
| FY2023 | $7.3M | -39.9% |
| FY2022 | $12.2M | +193.0% |
| FY2021 | $4.2M | - |
| FY2016 | - | - |
| FY2015 | $1.8K | +796.6% |
| FY2014 | $205 | -81.7% |
| FY2012 | $1.1K | -91.9% |
| FY2011 | $13.9K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026